FindTrial
Sign In

Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00318604
Enrollment
Unknown
Registered
2006-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2006-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer, Head and Neck Cancer

Keywords

plasma circulating DNA, hean and neck cancers, esophageal cancer, localized head and neck cancers, localized esophageal cancer

Brief summary

This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.

Interventions

None listed

Sponsors

Far Eastern Memorial Hospital
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Head and neck cancers * Esophageal cancer * Undergoing anti-cancer treatments

Exclusion criteria

* No distant metastasis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026